| EX1920 t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE |
| Specimen: |
3 mL (2 mL min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Clinical history is mandatory. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 6 hrs |
72 hrs |
NA |
|
| Method: |
Real-Time PCR |
| Comment: |
|
| Report: |
Contact us to know the TAT. |
| Usage: |
Chromosomal rearrangements can produce tumorigenic fusion genes. This mechanism is seen in 15-25% of Leukemias, Lymphomas & Sarcomas. Fusions can be produced by translocations, inversions, or deletions. Specific gene fusions in a patient’s tumor cells have an important bearing on the management & prognosis. This assay detects the MLL-AF9 fusion gene which is the most common MLL abnormality in AML. |
| Doctor Specialty: |
Oncologist |
| Disease: |
Leukemia |
| Components: |
|
| Courier Charges: |
0.00 |
| Home Collection: |
Available (*T&C Apply) |
| Department: |
MOLECULAR DIAGNOSTICS |
| Pre Test Information: |
Clinical history is mandatory. |
Reviews
There are no reviews yet.